bpc-157 mechanism of action studies effects benefits research Mechanisms of Action, Biological Characteristics, and Future Prospects BPC-157 10mg Guide | Research
Description
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites
Author contributions CC, KR, and FV conceived the study
Read the full study: Therapeutic Potential of Pro-Angiogenic BPC157 is Associated with VEGFR2 Activation and Up-Regulation (J Mol Med 2017)
Jest to kompleks badawczy nie jest produktem leczniczym i nie posiada rejestracji do stosowania klinicznego w Polsce ani UE
Management: Most side effects can be managed with OTC therapies
